176 related articles for article (PubMed ID: 37223373)
1. Effect of low-calorie diet on psoriasis severity index, triglycerides, liver enzymes, and quality of life in psoriatic patients with non-alcoholic fatty liver disease.
Ismail AMA; Saad AE; Draz RS
Reumatologia; 2023; 61(2):116-122. PubMed ID: 37223373
[TBL] [Abstract][Full Text] [Related]
2. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic Fatty Liver Disease Among Iraqi Patients With Psoriasis: A Case-Control Study.
Dhaher SA; Hilfi NZ; Abdullah MA
Cureus; 2024 Apr; 16(4):e57487. PubMed ID: 38707119
[TBL] [Abstract][Full Text] [Related]
4. Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial.
Guida B; Napoleone A; Trio R; Nastasi A; Balato N; Laccetti R; Cataldi M
Clin Nutr; 2014 Jun; 33(3):399-405. PubMed ID: 24120032
[TBL] [Abstract][Full Text] [Related]
5. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
Al-Mutairi N; Nour T
Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
[TBL] [Abstract][Full Text] [Related]
6. Erectile dysfunction and metabolic syndrome components in obese men with psoriasis: response to a 12-week randomized controlled lifestyle modification program (exercise with diet restriction).
Ismail AMA; Hamed DE
Ir J Med Sci; 2024 Feb; 193(1):523-529. PubMed ID: 37258850
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
Petridis A; Panagakis P; Moustou E; Vergou T; Kallidis P; Mandekou-Lefaki I; Chaidemenos G; Sotiriadis D; Alexopoulou G; Haratsis Y; Antoniou C
J Eur Acad Dermatol Venereol; 2018 May; 32(5):768-775. PubMed ID: 29356149
[TBL] [Abstract][Full Text] [Related]
8. The effect of weight loss in obese patients with chronic stable plaque-type psoriasis.
Roongpisuthipong W; Pongpudpunth M; Roongpisuthipong C; Rajatanavin N
Dermatol Res Pract; 2013; 2013():795932. PubMed ID: 24159327
[TBL] [Abstract][Full Text] [Related]
9. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
Spuls PI; Hooft L
Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
[TBL] [Abstract][Full Text] [Related]
10. Aggressive weight-loss program with a ketogenic induction phase for the treatment of chronic plaque psoriasis: A proof-of-concept, single-arm, open-label clinical trial.
Castaldo G; Rastrelli L; Galdo G; Molettieri P; Rotondi Aufiero F; Cereda E
Nutrition; 2020 Jun; 74():110757. PubMed ID: 32222582
[TBL] [Abstract][Full Text] [Related]
11. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial.
Gisondi P; Del Giglio M; Di Francesco V; Zamboni M; Girolomoni G
Am J Clin Nutr; 2008 Nov; 88(5):1242-7. PubMed ID: 18996858
[TBL] [Abstract][Full Text] [Related]
12. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial.
Rezaei S; Akhlaghi M; Sasani MR; Barati Boldaji R
Nutrition; 2019 Jan; 57():154-161. PubMed ID: 30170304
[TBL] [Abstract][Full Text] [Related]
13. The effect of hydroxy citric acid supplementation with calorie-restricted diet on metabolic, atherogenic and inflammatory biomarkers in women with non-alcoholic fatty liver disease: a randomized controlled clinical trial.
Arefhosseini S; Tutunchi H; Nomi-Golzar S; Mahboob S; Pouretedal Z; Ebrahimi-Mameghani M
Food Funct; 2022 May; 13(9):5124-5134. PubMed ID: 35416190
[TBL] [Abstract][Full Text] [Related]
14. Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis.
Peinemann F; Harari M; Peternel S; Chan T; Chan D; Labeit AM; Gambichler T
Cochrane Database Syst Rev; 2020 May; 5(5):CD011941. PubMed ID: 32368795
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial.
Fathi M; Alavinejad P; Haidari Z; Amani R
Biol Trace Elem Res; 2020 Oct; 197(2):394-404. PubMed ID: 32020523
[TBL] [Abstract][Full Text] [Related]
16. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
[TBL] [Abstract][Full Text] [Related]
17. Antistreptococcal interventions for guttate and chronic plaque psoriasis.
Dupire G; Droitcourt C; Hughes C; Le Cleach L
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011571. PubMed ID: 30835819
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
[TBL] [Abstract][Full Text] [Related]
19. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.
Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Azadbakht L
Nutrition; 2014; 30(7-8):814-21. PubMed ID: 24984998
[TBL] [Abstract][Full Text] [Related]
20. Effect of CoQ10 Administration to Psoriatic Iraqi Patients on Biological Therapy Upon Severity Index (PASI) and Quality of Life Index (DLQI) Before and After Therapy.
Al-Oudah GA; Sahib AS; Al-Hattab MK; Al-Ameedee AA
J Popul Ther Clin Pharmacol; 2022; 29(2):e52-e60. PubMed ID: 35848197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
